WEBINAR REPLAY: "Chest Tube Management in Cardiac Surgery" | ERAS Cardiac Society Webinar in collaboration with CTSNet

Key speakers Marc Gillinov, MD, Jurij M. Kalisnik, MD, and Lenard Conradi, MD discuss the clinical implications of retained blood, current strategies in chest tube management, and the benefits of posterior pericardiotomy.
Webinar moderated by Kevin Lobdell, MD, and Marc Gerdisch, MD.



Clear Catheter Systems Announces Publication of Pre-Clinical Data

For Immediate Release

Clear Catheter Systems Announces Publication of Pre-Clinical Data Demonstrating
Improved Drainage with the PleuraFlow® Active Tube Clearance® System

BEND, Oregon – Clear Catheter Systems announced the publication of Pre-Clinical data
in the May, 2010 edition of the Interactive Cardiovascular and Thoracic Surgery Journal.
The study, entitled “Improved drainage with active chest tube clearance”, was
performed at Cleveland Clinicʼs Lerner Research Institute, under the Direction of cardiac
surgery researcher, Dr. Kiyotaka Fukamachi and Dr. Marc Gillinov, staff cardiac surgeon
at Cleveland Clinic and co-inventor of this technology.

The study evaluated the PleuraFlow®, a novel active chest tube clearance system, vs
conventional chest tubes. Chest tubes are routinely used to drain blood and other
matter from the chest cavity after heart surgery.

“Clogging of the chest tube with blood in the setting of continued postoperative drainage
can lead to complications and even death,” says Dr. Kiyotaka Fukamachi. “In the
laboratory we are finding that active chest tube clearance improves drainage and
reduced the degree of retained hemothorax compared to a standard chest tube.”
According to Edward Boyle, CEO of Clear Catheter Systems, “This is the first study to
demonstrate that active chest tube clearance improved drainage compared to a
standard chest tube of the same size.” The company is developing the PleuraFlow®
System, a chest tube that includes a proprietary active tube clearance mechanism for
use after heart and lung surgery.

Said Dr. Gillinov, “This study suggests that an active tube clearance system may provide
clinicians with a better way to safely manage the growing number of patients with a
tendency to bleed when on powerful antiplatelet agents and who need to maintain
functioning chest tubes while their platelets are replaced in the early postoperative

The company is currently applying for regulatory approval to market this device in North
America and Europe.

About Clear Catheter Systems
Clear Catheter Systems (www.clearcatheter.com) is a medical device company located
in Cleveland, Ohio and Bend, Oregon, developing proprietary medical tube clearance
platform based on technology developed at Cleveland Clinic and MDI Partners,
(www.mdipartnersllc.com). Clear Catheterʼs ultimate goal is to develop its tube
clearance platform to help make surgery safer for heart, lung and trauma patients, as
well as in markets beyond cardiothoracic surgery.

About Cleveland Clinic Innovations
Innovations, the commercialization and innovation arm of Cleveland Clinic, promote
innovation and are responsible for commercialization of all Cleveland Clinic
technologies. CC Innovations advances product-oriented innovation and transforms
promising therapies, devices and diagnostics into beneficial medical products, via spinoff
companies, licensees and equity partnerships.

For further information please contact:
Kelly Herman
(541) 419-8855